US to pay $2bn to Pfizer and BioNTech for vaccine doses
This will buy 100-million doses should the vaccine be approved, with the companies also agreeing to supply the UK with 30-million for an unknown sum
22 July 2020 - 18:22
Bengaluru/New Jersey — The US government will pay $1.95bn to buy 100-million doses of Pfizer and German biotech firm BioNTech’s Covid-19 vaccine candidate if they are able to successfully develop one, the companies said on Wednesday.
The contract is the most the US has agreed to spend on a vaccine yet, but the previous deals the government signed helped pay for drugmakers’ development costs. Pfizer and BioNTech will not receive any money from the government unless their vaccine is deemed to be safe and effective and is successfully manufactured, according to a Pfizer spokesperson...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.